These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15238641)

  • 21. SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature.
    Siau K; Laversuch CJ
    Rheumatol Int; 2010 Jun; 30(8):1085-8. PubMed ID: 19551383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations.
    Massara A; Cavazzini PL; Trotta F
    Rheumatology (Oxford); 2006 Jun; 45(6):730-3. PubMed ID: 16403830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.
    Löwing K; Aström E; Oscarsson KA; Söderhäll S; Eliasson AC
    Acta Paediatr; 2007 Aug; 96(8):1180-3. PubMed ID: 17578486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of SAPHO with pamidronate.
    Courtney PA; Hosking DJ; Fairbairn KJ; Deighton CM
    Rheumatology (Oxford); 2002 Oct; 41(10):1196-8. PubMed ID: 12364646
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates.
    Just A; Adams S; Brinkmeier T; Barsegian V; Lorenzen J; Schilling F; Frosch P
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):657-60. PubMed ID: 18266863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome.
    Touma Z; Arayssi T
    J Clin Rheumatol; 2007 Dec; 13(6):338-40. PubMed ID: 18176144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SAPHO syndrome presenting as septic arthritis in the hip.
    O'Connor DA; Ridha H; Roche CJ; O'Sullivan M
    Ir Med J; 2003 Feb; 96(2):41-2. PubMed ID: 12674151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome.
    Davenport A; Stearns MP
    Nephrology (Carlton); 2007 Aug; 12(4):386-90. PubMed ID: 17635755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.
    Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K
    Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder?
    Adib N; Davies K; Grahame R; Woo P; Murray KJ
    Rheumatology (Oxford); 2005 Jun; 44(6):744-50. PubMed ID: 15728418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients.
    Delattre E; Guillot X; Godfrin-Valnet M; Prati C; Wendling D
    Joint Bone Spine; 2014 Oct; 81(5):456-8. PubMed ID: 24561020
    [No Abstract]   [Full Text] [Related]  

  • 32. Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey.
    Witt M; Meier J; Hammitzsch A; Proft F; Schulze-Koops H; Grunke M
    Semin Arthritis Rheum; 2014 Jun; 43(6):745-50. PubMed ID: 24816195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Methotrexate to treat SAPHO syndrome with keloidal scars].
    Azevedo VF; Dal Pizzol VI; Lopes H; Coelho SP; Czeczko LE
    Acta Reumatol Port; 2011; 36(2):167-70. PubMed ID: 21841736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.
    Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S
    Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.
    Simm PJ; Allen RC; Zacharin MR
    J Pediatr; 2008 Apr; 152(4):571-5. PubMed ID: 18346517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate.
    Yamazaki Y; Satoh C; Ishikawa M; Notani K; Nomura K; Kitagawa Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jul; 104(1):67-71. PubMed ID: 17197211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis of the jaw associated with pamidronate therapy.
    Zarychanski R; Elphee E; Walton P; Johnston J
    Am J Hematol; 2006 Jan; 81(1):73-5. PubMed ID: 16369966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
    Hurtado-Nedelec M; Chollet-Martin S; Nicaise-Roland P; Grootenboer-Mignot S; Ruimy R; Meyer O; Hayem G
    Rheumatology (Oxford); 2008 Aug; 47(8):1160-7. PubMed ID: 18559374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribbing disease: radiographic and biochemical characterization, lack of response to pamidronate.
    Ziran N; Hill S; Wright ME; Kovacs J; Robey PG; Wientroub S; Collins MT
    Skeletal Radiol; 2002 Dec; 31(12):714-9. PubMed ID: 12483434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
    Iqbal M; Kolodney MS
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S118-20. PubMed ID: 15858507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.